Articles tagged with Chronic Obstructive Pulmonary Disease
A study by Helmholtz Munich researchers found that certain subtypes of COPD are associated with changes in the lung microbiome, which may promote pathogenic bacteria. The findings suggest personalized medicine approaches should consider the microbiome when treating patients with specific COPD subtypes.
Researchers found that new opioid use among older adults with COPD is associated with a higher risk of coronary artery disease-related death. The study suggests that opioids may have negative effects on the heart, including lower blood oxygen levels and increased inflammatory factors.
Researchers found that faster administration of care was linked with lower mortality in patients with sepsis and septic shock. The study suggests that hospitals and health care systems should invest in infrastructure to get antibiotics to patients as soon as possible.
In-hospital COPD mortality declined substantially between 2005 and 2014, with a 62% decrease in deaths among patients hospitalized for the condition. Women accounted for the majority of hospitalizations and in-hospital deaths, making up 57-58% and 51-55%, respectively.
BU researcher Avrum Spira recognized for his work on early detection of lung cancer using Percepta RNA biomarker, as well as development of new drugs for chronic obstructive pulmonary disease (COPD). His research has made a direct impact on diagnosis and daily care of patients with lung cancer and COPD in the past 20 years.
A randomized controlled trial found that online pulmonary rehabilitation was non-inferior to in-person classes in improving exercise capacity and symptom control among patients with moderate COPD. The study used the MyPR application, which is free for UK patients with advanced COPD.
A new study found that smokers without chronic obstructive pulmonary disease (COPD) who experience vascular pruning, or the reduction of distal pulmonary blood vessels, are at a higher risk of death. Vascular pruning was not associated with an increased risk of death in smokers with COPD.
A new COPD National Action Plan was released by the NHLBI, outlining key goals to raise public awareness, advance research, improve patient care, and develop management strategies. The plan aims to empower people with COPD to recognize and reduce its burden, as well as promote education and training for healthcare professionals.
UK researchers have made a breakthrough in treating severe lung disease by developing a home ventilation therapy that reduces hospital readmissions. The study, published in the Journal of the American Medical Association, found patients using this treatment were two-thirds less likely to be readmitted within 28 days.
A study published in JAMA found that adding home noninvasive ventilation to oxygen therapy for patients with persistent hypercapnia following a COPD flare-up significantly reduced time to hospital readmission or death. The 12-month risk of readmission or death was 63% vs 80% in the treatment and control groups, respectively.
Acute COPD exacerbations significantly increase the risk of heart attack and stroke in people with cardiovascular disease or at high CVD risk. Researchers found that odds of these events were nearly four-fold higher within 30 days after an exacerbation.
Researchers found no evidence of increased risk of heart attack, depression, or self-harm in patients with COPD using varenicline. The medication is considered highly effective in helping smokers quit, addressing long-standing concerns among doctors.
A new study investigates the use of oxygen therapy via high-flow nasal tubes in patients with COPD experiencing exacerbations. The short-term trial found lower retained carbon dioxide levels compared to standard oxygen therapy, suggesting a potential benefit.
A new triple inhaler has shown a 20% reduction in chronic obstructive pulmonary disease (COPD) flare-ups in a year-long trial involving 2,691 patients. The study found that the inhaler improved lung function and reduced symptoms, with potential benefits for early diagnosis and targeted treatment.
A new study found that stem cell therapy reduces lung inflammation in a mouse model of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The treatment also improves lung structure, suggesting it may repair damaged lungs.
A new study reveals a significant decrease in airway wall cells and certain inflammatory cells in smokers and mild to moderate COPD patients. The findings challenge the widely accepted description of airway inflammation in these individuals, suggesting a more complex underlying mechanism.
The new guidelines cover antibiotic and corticosteroid therapy for outpatients with mild and moderate exacerbations. The recommendations also include starting pulmonary rehabilitation 3 weeks after discharge from hospital following a severe exacerbation.
Researchers discovered that cigarette smoke silences the lung's natural self-healing process by blocking key receptors. Increasing these receptors can restore repair and lead to increased production of vital proteins, offering new hope for developing therapies for COPD patients.
A diet rich in fruit and vegetables is associated with a significantly lower risk of chronic lung disease (COPD) in former and current smokers. The study found that each additional daily serving was linked to a 4-8% lower risk, with the strongest influence coming from apples, green leafy vegetables, and peppers.
Current and former smokers with medical comorbidities are more likely to use e-cigarettes, which may be seen as a safer alternative to combustible cigarettes. The study found that e-cigarette use continues to rise, especially among present smokers with asthma or cardiovascular disease.
A study analyzing over 1.5 million Medicare records found that ICU care for COPD, heart failure, and heart attack patients may not be more beneficial than regular hospital care, with significant differences in cost of care.
A new treatment targeting COPD and other lung diseases has been identified in a study published in The FASEB Journal. FPS-ZM1, a RAGE antagonist compound, reverses the inflammatory response and has a protective role in COPD, according to researchers.
Scientists have developed a model to predict the chances of developing COPD, a deadly lung disease, based on genetic variations and smoking habits. The study, involving over 350,000 participants from 13 countries, has identified new genetic variants associated with enhanced or worsened lung function in smokers and non-smokers.
Researchers have identified 13 new genetic regions linked to chronic obstructive pulmonary disease (COPD), as well as overlap with asthma and pulmonary fibrosis. The study provides insight into the genetic basis of COPD and may lead to improved therapies for patients.
A new study found that dying at home or in hospital is influenced by factors such as wealth, location, and the presence of multiple diseases. The study showed a decrease in hospital deaths from COPD and IPD after implementing an end-of-life care strategy, but did not see this effect for patients with multimorbidity.
A new study found that sepsis accounts for the highest rate of hospital readmissions and associated costs among four tracked conditions, including heart attack, heart failure, COPD, and pneumonia. The study highlights the need to improve sepsis outcomes and reduce readmissions.
Researchers developed a new mouse model that faithfully reproduces the pathologies of COPD and CF, revealing two key pathways: oxidative stress and protease-antiprotease imbalance. The model shows promise for developing new medication therapies.
A study on chronic obstructive pulmonary disease (COPD) found that 44% of patients were under-treated, while only 19% received recommended medication regimens. Patients who were under-treated had fewer exacerbations, indicating that ignoring guidelines may be beneficial in certain cases.
Scientists at Helmholtz Zentrum München discovered that the Wnt5a molecule disrupts lung cells' ability to repair damages in COPD. Stimuli like cigarette smoke lead to increased production of Wnt5a, impairing lung regeneration.
Researchers are developing new technologies to help patients with chronic conditions such as COPD and diabetes manage their health at home. The £10 million project will explore the use of wearable devices and data analytics to improve healthcare services. Seven UK universities and over 30 partners are involved in the research.
A study of 129,535 Americans aged 50+ found that never-smoking older African American women had the highest COPD prevalence, with 7% and 5.2% in White women, respectively. Hormones and second-hand smoke exposure may contribute to this vulnerability.
Patients with chronic lung disease living in deprived areas are more likely to be malnourished than those from wealthier postcodes. A QUT study assessing 424 outpatients found 22% were at risk of malnutrition, with those from more deprived areas significantly more likely to be at risk.
Researchers found that patients with pulmonary function testing had a lower risk of hospitalization and death from COPD. The study suggests that increasing testing for suspected cases could improve patient care and reduce healthcare costs.
Researchers develop a simple tool to identify patients with chronic obstructive pulmonary disease (COPD) in primary care settings using five questions and peak expiratory flow meters. The approach shows high sensitivity and specificity rates, and may improve COPD diagnosis, quality of life, and health outcomes.
Scientists created an airway-on-a-chip that simulates the effects of smoking on human lungs, revealing changes in gene expression and cilia beat patterns. The technology also showed promise for testing e-cigarettes and identifying potential therapies for COPD.
Researchers have developed a device that mimics the effects of cigarette smoke on human lungs, providing new insights into how non-smokers and COPD patients respond to smoke. The device enables the comparison of physiological responses in healthy individuals and COPD patients before and after exposure to cigarette smoke.
Researchers studied COPD patients with moderate oxygen deficiency and found no significant difference in time to death, hospitalizations, or quality of life between those who received supplemental oxygen and those who didn't. The study suggests that long-term oxygen therapy may not be necessary for all COPD patients.
A new study published in the New England Journal of Medicine found that long-term oxygen treatment does not improve survival or reduce hospital admissions for patients with chronic obstructive pulmonary disease (COPD) and moderately low blood oxygen levels. Researchers say these results underscore the need for new treatments for COPD.
A single home visit significantly increases patient adherence to office visits and inhaler use, reducing severe exacerbations and emergency department visits. After the intervention, patients exhibited a 40% decrease in ED visits and improved maintenance inhaler use.
A recent study found that only 29% of patients with COPD had spirometry testing, leading to misdiagnoses in 31.6%. This highlights the need for education and training on COPD diagnosis to improve accuracy.
Two studies found that patients with a higher resting heart rate after an exacerbation are at risk for recurrent exacerbations, while hand grip strength is associated with fewer COPD exacerbations. Muscle weakness is linked to exercise limitation and exacerbations, making hand grip strength a useful marker.
Resveratrol, a compound found in red wine and grapes, has been shown to reduce inflammation induced by bacterial pathogens that cause respiratory diseases such as asthma and COPD. The study identified a novel mechanism by which resveratrol suppresses inflammation by upregulating a negative regulator called MyD88 short.
Research published in the American Journal of Respiratory and Critical Care Medicine found that acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with significant long-term lung function loss. Those with mild COPD experienced the greatest FEV1 decline, with each exacerbation linked to an additional 23 m...
A new study challenges the traditional efficacy trial model by using real-world patients and GP practices to test COPD treatments. The Salford Lung Study found that a once-daily treatment regimen was associated with lower rates of exacerbations without increased risk of serious adverse events.
Patients with chronic obstructive pulmonary disease (COPD) who engage in high levels of physical activity are less likely to develop anxiety or depression, with a 15% reduced risk. Mental disorders are common in COPD patients, affecting approximately 40% of the population.
Experts predict a significant increase in lung disease cases due to rising smoking rates and longer life expectancy, with over 1.3 million cases projected in England by 2030. The condition is expected to cost £2.5 billion annually, with more women than men affected, mainly due to their longer average lifespan.
Researchers analyzed 4,500 US hospitals' data and found that facilities with high readmission rates had better mortality scores in specific conditions like heart failure, COPD, and stroke. This challenges the commonly used measure of hospital quality by CMS.
Recent literature suggests N-acetylcysteine reduces frequency of COPD exacerbations in stable patients taking 1,200 mg daily. However, its benefits for acute exacerbations are uncertain and require further investigation.
Researchers found that new opioid use among older adults with chronic obstructive pulmonary disease (COPD) is associated with a significantly increased risk of respiratory-related complications and death. The study, published in the European Respiratory Journal, suggests that even lower-dose opioids may pose risks for this population.
A simple 7-item screening tool has been developed to identify patients at risk for chronic obstructive pulmonary disease (COPD). The tool uses predictive factors such as gender, age, smoking history, and breathlessness to assess COPD risk in primary care settings.
A recent study found that depression decreases adherence to COPD maintenance medications in older adults, with average monthly adherence peaking at 57% and decreasing to 25% within six months. Clinicians should be aware of the development of depression in newly-diagnosed patients with COPD.
A quarter of COPD patients are frail but can respond favourably to exercise rehabilitation. Frail patients who completed the programme scored better in measures of breathlessness and exercise performance, with 61% no longer meeting frailty criteria after rehabilitation.
A new study from UTMB reveals that pulmonary rehabilitation therapy is underutilized despite its health benefits and cost-effectiveness in managing chronic obstructive pulmonary disease. The study found that the majority of economic burden of COPD stems from hospitalizations, which can be reduced by PR.
A study of 417,494 older adults with COPD, asthma, or both found a significant increase in nontuberculous mycobacteria pulmonary disease among current and former inhaled corticosteroid users. Researchers identified fluticasone as a potential contributor to the increased risk.
A new report highlights seven areas of focus within COPD care, including improving access to education, medications, and non-medication interventions. The report also emphasizes the need for more research funding and development of cost-effective treatments.
Exacerbations of COPD accelerate lung-function loss among patients with mild disease, according to researchers. The study found that exacerbations resulted in significant additional decline in FEV1 lung function, particularly among GOLD 1 patients.
A landmark survey by the ATS and Sunovion Pharmaceuticals Inc. reveals that seven in ten pulmonologists believe hand-held small volume nebulizers are more effective than metered-dose inhalers (MDIs) for managing acute exacerbations of COPD, particularly in severe cases. The survey also highlights gaps in physicians' knowledge about tre...
A new study reveals that smokers without COPD diagnosis often experience respiratory symptoms, and those with 'normal' breathing tests still require medical attention. Researchers are exploring the use of bronchodilator medication to improve symptoms for this patient group.
A new study found that exacerbations in COPD patients are associated with excess loss of lung function, particularly in those with mild disease. The researchers analyzed data from over 2,800 patients and found that each exacerbation was linked to a decline in FEV1, the amount of air a person can forcefully blow out of their lungs.
Researchers discovered that NETs are strongly correlated with airway infection and disease severity in COPD patients, suggesting a potential biomarker for identifying those at risk of progression. This finding may lead to the development of new treatments targeting NET formation.